Skip to main content

Month: September 2023

Stephen C. VanSuch Joins Stifel to Lead Youngstown Market

Veteran Financial Advisor and Manager Was Responsible for $500 Million in Client Assets at Merrill ST. LOUIS, Sept. 28, 2023 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced that Stephen C. VanSuch has joined the firm’s Stifel, Nicolaus & Company, Incorporated broker-dealer subsidiary as Managing Director/Investments and Branch Manager in Canfield, Ohio. In this role, he will work with Ralph Fajack, Branch Manager, to lead the Youngstown market. Mr. VanSuch comes to Stifel after spending 24 years as a Managing Director at Merrill Lynch, where he was responsible for approximately $500 million in client assets and previously served as a Senior Resident Director.   Stifel’s history in the Mahoning Valley region dates back decades, furthered by its 2008 acquisition of Youngstown-based Butler Wick & Company,...

Continue reading

Erayak Power Solution Group Inc. In Discussions with Potential Strategic Partners to Expand Market Opportunities and Product Offerings

Wenzhou, China, Sept. 28, 2023 (GLOBE NEWSWIRE) — Erayak Power Solution Group Inc. (“Erayak” or the “Company”) (Nasdaq: RAYA), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, is pleased to announce that the Company is discussing with potential strategic partners to expand its market opportunities and product reach. One of the potential partners is a diversified energy company that produces and markets fuels, natural gases, and electricity. The company has been established in China for nearly 40 years and is actively involved in the entire Chinese energy industry supply chain, from both upstream to downstream operations. Erayak is looking to share experience, technology, and industry expertise to create mutually beneficial partnerships to develop domestic...

Continue reading

Toll Brothers Opens New Waterfront Community in St. Johns, Florida

Shores at Rivertown offers single-family homes and waterfront townhomes with access to optional boat slips and within walking distance of master-planned amenitiesToll Brothers Shores at RiverTownToll Brothers’ new waterfront community, Shores at RiverTown, is now open with single-family homes and waterfront townhomes in St. Johns, FloridaToll Brothers Shores at RiverTown“We are excited to bring our luxury home designs to this well-known master-planned community where family and lifestyle remain key for our home buyers,” said Greg Netro, Group President of Toll Brothers in North Florida.Toll Brothers Shores at RiverTownShores at RiverTown will offer Toll Brothers single-family homes ranging from 1,607 to 3,000+ square feet and low-maintenance, waterfront townhomes from 2,041 to 2,394+ square feet.JACKSONVILLE,...

Continue reading

Global Phase Transfer Catalyst (PTC) Market Size to Reach USD 2037.7 Million in 2032 | Emergen Research

Increasing adoption of green chemistry in organic synthesis is one of the key factors driving market revenue growth Vancouver, Sept. 28, 2023 (GLOBE NEWSWIRE) — The global Phase Transfer Catalyst (PTC) market size was USD 1,217.6 Million in 2022 and is expected to register a steady revenue CAGR of 5.3% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption for green chemistry in organic synthesis is a key factors driving market revenue growth. A PTC is a type of heterogeneous catalysis that allows a reactant to migrate from one phase to another while the reaction is taking place. This catalyst acts as a detergent, allowing salts to be dissolved into the organic phase. PTC catalyst products are widely used by the healthcare sector for a range of processes, including production of pharmaceutical...

Continue reading

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals

Transformative acquisition and purchase order enables Sharps to commercialize its innovative copolymer prefillable syringe systems to the healthcare market Company has a capitalization strategy through debt that has resulted in a signed term sheet with a leading middle-market lender for up to $75 Million NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, issues a shareholder update from Robert Hayes, the Company’s Chief Executive Officer. Dear Fellow Shareholders: I am pleased to update you on Sharps’ recently signed Asset Purchase Agreement to acquire the InjectEZ facility, a specialty prefillable syringe manufacturing facility, and the associated $400 Million...

Continue reading

Grupo Bimbo Will Donate More Than 2.8 Million Slices of Bread to Help Those Who Need it Most

Through the Bimbo Global Race, Grupo Bimbo committed to donating 20 slices of bread for each person registered. This year, the Bimbo Global Race had 120 thousand people in the physical race globally and more than 300 thousand participants, including virtual runners. The United States – where Bimbo Bakeries USA, part of Grupo Bimbo, is headquartered – was among the countries with the highest number of participants this year.HORSHAM, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Grupo Bimbo, the world’s leading bakery and parent company to Bimbo Bakeries USA, celebrated the 8th Bimbo Global Race, a social cause event to support active lifestyles and food donations to vulnerable communities. This year’s event had more than 300 thousand participants in 24 different cities from 17 countries worldwide. Thanks to the participation of hundreds...

Continue reading

Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease

Pombiliti + Opfolda LogoPombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) Approved in ERT-Experienced Adults First and Only Two-Component Therapy for Eligible Adults Living with Late-onset Pompe Disease Amicus Therapeutics to Host Conference Call Today at 12:00 p.m. ET PHILADELPHIA, Sept. 28, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has approved Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules. This two-component therapy is indicated for adults living with late-onset Pompe disease (LOPD) weighing ≥40 kg and who are not improving on their current enzyme replacement therapy (ERT). Late-onset Pompe disease is a rare, debilitating, and life-threatening lysosomal disorder caused...

Continue reading

Servus Credit Union continues its upward asset growth trajectory

EDMONTON, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Servus Credit Union Ltd. (Servus) continued its growth trajectory in its third quarter of 2023, reaching $19.8 billion in assets – up $1.6 billion (9.2%) from the same period last year. This growth supports Servus’s continued strategic focus on and investment in enhanced member experience. Year-to-date net interest income continued to trend positively with an increase of 7.6% over the prior year due to strong deposit and loan growth. While year-over-year operating expenses were higher due to continued investment in technology, products, services and growth-driving initiatives, operating expenses were reduced this quarter compared to the second quarter of 2023. “Since 2022, we’ve been positioning Servus for the future by reimagining how Servus can best support...

Continue reading

Syneos Health Closes Transaction with Private Investment Firms

Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) — Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital. As a result of the transaction, Syneos Health is now a privately held company. With the support of its new private investors, the Company will be poised to further accelerate its transformation, fuel investments in technology that better differentiate its integrated solutions and expand its commitment to better serve customers. Under...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.